HNGE stock news · Hinge Health
Get alerts for HNGE
Follow Hinge Health (HNGE) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for HNGEHinge Health shared its Q3 results, showing $235 million in sales, a 52% jump from last year.
Good for HNGEHinge Health reported $235 million in Q3 sales, up 52% from a year earlier, and raised its 2026 sales forecast to $879-$881 million. This points to a stronger outlook.
Hinge Health, Inc. discloses a significant definitive agreement (HNGE).
NeutralHinge Health, Inc. has filed a Form 8-K regarding a material definitive agreement, which indicates a significant change in its financial obligations. This could have implications for its operational strategy and investor sentiment, warranting immediate attention from market participants.
According to Jim Cramer, investors should consider purchasing shares of Hinge Health following their outstanding quarterly performance.
Good for HNGEJim Cramer has highlighted Hinge Health as a strong buy after the company reported impressive quarterly results and raised its sales guidance for FY2026. This endorsement is likely to attract immediate investor attention and could lead to a positive price movement in Hinge Health's stock.